Top Emerging Trends

Recent Posts

FDA Advisory Committee Votes to Recommend Keeping Anti-Diabetes Drug Avandia On The Market
Posted on 18 Jul 2010 by Tom Moylan

GAITHERSBURG, Md. - (Mealey's) A majority of Food and Drug Administration advisers voted July 14 to keep Avandia on the market but split on whether the anti-diabetes drug made by GlaxoSmithKline PLC (GSK) should carry additional warnings about its... Read More

Glaxo to take $2.36 Billion Charge to Reflect Settlement of Most Avandia and Paxil Product Liability Cases and Other Legal Issues
Posted on 17 Jul 2010 by Tom Moylan

LONDON - (Mealey's) GlaxoSmithKline PLC (GSK) on July 15 said it expects to take a $2.36 billion charge against earnings to settle several legal issues, including settling "the substantial majority" of Avandia product liability cases and... Read More

Chinese Drywall - Update on Litigation, Settlements, and Insurance Claims
Posted on 21 Oct 2010 by Ellen Clarke and Sallie Kraus

By Ellen Clarke and Sallie Kraus, Attorneys at Law The pace of litigation in the Chinese drywall ("CDW") claims has escalated in recent months. It is alleged that the gypsum that was used to manufacture that drywall came from particular... Read More